Tang Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,743,619
| Closed | -$1.7M | – | 155 |
|
|
2024
Q2 | $1.7M | Buy |
1,743,619
+300,000
| +21% | +$292K | 0.17% | 83 |
|
|
2024
Q1 | $2.28M | Sell |
1,443,619
-2,943,619
| -67% | -$4.65M | 0.24% | 74 |
|
|
2023
Q4 | $3.48M | Sell |
4,387,238
-779,716
| -15% | -$618K | 0.32% | 73 |
|
|
2023
Q3 | $4.03M | Buy |
5,166,954
+279,716
| +6% | +$218K | 0.57% | 48 |
|
|
2023
Q2 | $4.52M | Buy |
+4,887,238
| New | +$4.52M | 0.67% | 42 |
|